1Department of Immunology, School of Medicine,UConn Health, 2Center for Molecular Discovery,University of New Mexico Health Sciences Center, 3Comprehensive Cancer Center,University of New Mexico Health Sciences Center, 4Department of Pathology,University of New Mexico Health Sciences Center, 5Autophagy, Inflammation, & Metabolism (AIM) Center,University of New Mexico
Summary
Este protocolo describe un método de cribado de alto rendimiento basado en citometría de flujo para identificar fármacos de moléculas pequeñas que inhiben la activación de la integrina β2 en neutrófilos humanos.
